Abstract: The aim of the present study is to develop and optimize self-nanoemulsifying drug delivery systems (SNEDDS) to improve the per-oral bioavailability of poorly soluble herb active ingredient, Dihydromyricetin (DMY), and to evaluate its characterization and in vitro performance. Solubility of DMY was estimated in various vehicles to select proper components combinations. MCT(oil), Cremophor-RH40 or Tween-80 (surfactants) as well as glycerol (co-surfactants) were employed to construct pseudo-ternary phase diagrams. Combine with characterization, emulsification grade, thermodynamic stability and robustness to dilution tests were selected most optimize formulations. Formulations composed of MCT: Cremophor-RH40: glycerol = 9:14:7 was selected. The partical sizes of the DMY-SNEDDS (O/W) was 56.54±0.36 nm, zeta-Potential was -5.21±0.54 mV, PDI value was 0.312±0.08, the drug loading was 45mg/kg. The in vitro release profile of DMY-SNEDDS was found significant in comparison to the plain DMY suspension. These results demonstrate the potential use of SNEDDS for improving the bioavailability of poor water soluble compounds, such as DMY.
Keywords: Dihydromyricetin; self-nanoemulsifying drug delivery systems; bioavailability; characterization; drug release
Abstract: The aim of the present study is to develop and optimize self-nanoemulsifying drug delivery systems (SNEDDS) to improve the per-oral bioavailability of poorly soluble herb active ingredient, Dihydromyricetin (DMY), and to evaluate its characterization and in vitro performance. Solubility of DMY was estimated in various vehicles to select proper components combinations. MCT(oil), Cremophor-RH40 or Tween-80 (surfactants) as well as glycerol (co-surfactants) were employed to construct pseudo-ternary phase diagrams. Combine with characterization, emulsification grade, thermodynamic stability and robustness to dilution tests were selected most optimize formulations. Formulations composed of MCT: Cremophor-RH40: glycerol = 9:14:7 was selected. The partical sizes of the DMY-SNEDDS (O/W) was 56.54±0.36 nm, zeta-Potential was -5.21±0.54 mV, PDI value was 0.312±0.08, the drug loading was 45mg/kg. The in vitro release profile of DMY-SNEDDS was found significant in comparison to the plain DMY suspension. These results demonstrate the potential use of SNEDDS for improving the bioavailability of poor water soluble compounds, such as DMY.<br>关键词:二氢杨梅素; 自纳米乳化药物传递系统; 生物利用度; 表征; 药物释放
正在翻译中..